Logo image of CNDT

CONDUENT INC (CNDT) Stock Fundamental Analysis

USA - NASDAQ:CNDT - US2067871036 - Common Stock

2.84 USD
-0.12 (-4.05%)
Last: 9/19/2025, 8:00:00 PM
2.84 USD
0 (0%)
After Hours: 9/19/2025, 8:00:00 PM
Fundamental Rating

2

CNDT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 86 industry peers in the IT Services industry. CNDT may be in some trouble as it scores bad on both profitability and health. CNDT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CNDT had negative earnings in the past year.
CNDT had a negative operating cash flow in the past year.
CNDT had negative earnings in 4 of the past 5 years.
Of the past 5 years CNDT 4 years had a positive operating cash flow.
CNDT Yearly Net Income VS EBIT VS OCF VS FCFCNDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 0.40%, CNDT is in line with its industry, outperforming 48.28% of the companies in the same industry.
The Return On Equity of CNDT (1.09%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.4%
ROE 1.09%
ROIC N/A
ROA(3y)0.32%
ROA(5y)-0.6%
ROE(3y)-5.14%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
CNDT Yearly ROA, ROE, ROICCNDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

The Profit Margin of CNDT (0.32%) is comparable to the rest of the industry.
CNDT has a Gross Margin of 17.96%. This is amonst the worse of the industry: CNDT underperforms 83.91% of its industry peers.
In the last couple of years the Gross Margin of CNDT has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 0.32%
GM 17.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.32%
GM growth 5Y-3.05%
CNDT Yearly Profit, Operating, Gross MarginsCNDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

3

2. Health

2.1 Basic Checks

CNDT does not have a ROIC to compare to the WACC, probably because it is not profitable.
CNDT has less shares outstanding than it did 1 year ago.
CNDT has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CNDT has an improved debt to assets ratio.
CNDT Yearly Shares OutstandingCNDT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CNDT Yearly Total Debt VS Total AssetsCNDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.13, we must say that CNDT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CNDT (0.13) is worse than 79.31% of its industry peers.
CNDT has a Debt/Equity ratio of 0.68. This is a neutral value indicating CNDT is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.68, CNDT perfoms like the industry average, outperforming 40.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z 0.13
ROIC/WACCN/A
WACC9.33%
CNDT Yearly LT Debt VS Equity VS FCFCNDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.65 indicates that CNDT should not have too much problems paying its short term obligations.
CNDT's Current ratio of 1.65 is in line compared to the rest of the industry. CNDT outperforms 47.13% of its industry peers.
CNDT has a Quick Ratio of 1.65. This is a normal value and indicates that CNDT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CNDT (1.65) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
CNDT Yearly Current Assets VS Current LiabilitesCNDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for CNDT have decreased strongly by -89.66% in the last year.
CNDT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.36%.
CNDT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.56% yearly.
EPS 1Y (TTM)-89.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.14%
Revenue 1Y (TTM)-14.36%
Revenue growth 3Y-6.76%
Revenue growth 5Y-5.56%
Sales Q2Q%-8.94%

3.2 Future

The Earnings Per Share is expected to grow by 41.77% on average over the next years. This is a very strong growth
Based on estimates for the next years, CNDT will show a small growth in Revenue. The Revenue will grow by 6.90% on average per year.
EPS Next Y43.12%
EPS Next 2Y41.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.55%
Revenue Next 2Y-1.51%
Revenue Next 3Y6.9%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNDT Yearly Revenue VS EstimatesCNDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
CNDT Yearly EPS VS EstimatesCNDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNDT. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 556.86, which means the current valuation is very expensive for CNDT.
62.07% of the companies in the same industry are cheaper than CNDT, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, CNDT is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 556.86
CNDT Price Earnings VS Forward Price EarningsCNDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300 400 500

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CNDT is valued cheaply inside the industry as 88.51% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.91
CNDT Per share dataCNDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CNDT does not grow enough to justify the current Price/Earnings ratio.
CNDT's earnings are expected to grow with 41.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.77%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CNDT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONDUENT INC

NASDAQ:CNDT (9/19/2025, 8:00:00 PM)

After market: 2.84 0 (0%)

2.84

-0.12 (-4.05%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners71.39%
Inst Owner Change-3.6%
Ins Owners8.85%
Ins Owner Change25.65%
Market Cap448.63M
Analysts86.67
Price Target7.17 (152.46%)
Short Float %2.16%
Short Ratio3.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)2.53%
DP100%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.94%
Min EPS beat(2)12.1%
Max EPS beat(2)17.77%
EPS beat(4)3
Avg EPS beat(4)-5.52%
Min EPS beat(4)-63.4%
Max EPS beat(4)17.77%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.3%
Min Revenue beat(2)-5.4%
Max Revenue beat(2)-3.2%
Revenue beat(4)0
Avg Revenue beat(4)-3.73%
Min Revenue beat(4)-5.4%
Max Revenue beat(4)-3.13%
Revenue beat(8)3
Avg Revenue beat(8)-1.59%
Revenue beat(12)3
Avg Revenue beat(12)-1.64%
Revenue beat(16)3
Avg Revenue beat(16)-1.64%
PT rev (1m)1.08%
PT rev (3m)1.08%
EPS NQ rev (1m)13.33%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.33%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)-0.96%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-1.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 556.86
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 3.48
EV/EBITDA 6.91
EPS(TTM)-0.55
EYN/A
EPS(NY)0.01
Fwd EY0.18%
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS19.7
BVpS5.82
TBVpS0.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.4%
ROE 1.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.32%
GM 17.96%
FCFM N/A
ROA(3y)0.32%
ROA(5y)-0.6%
ROE(3y)-5.14%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.32%
GM growth 5Y-3.05%
F-Score3
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA 5.23
Cap/Depr 25.67%
Cap/Sales 1.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z 0.13
F-Score3
WACC9.33%
ROIC/WACCN/A
Cap/Depr(3y)43.07%
Cap/Depr(5y)40.25%
Cap/Sales(3y)2.71%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.14%
EPS Next Y43.12%
EPS Next 2Y41.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.36%
Revenue growth 3Y-6.76%
Revenue growth 5Y-5.56%
Sales Q2Q%-8.94%
Revenue Next Year-6.55%
Revenue Next 2Y-1.51%
Revenue Next 3Y6.9%
Revenue Next 5YN/A
EBIT growth 1Y-286.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year607.08%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-720%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-135.43%
OCF growth 3YN/A
OCF growth 5YN/A